ATXI · Avenue Therapeutics, Inc.
$0.26
+0.00 (+0.00%)
At close · Aug 17
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors individually and collectively cause substantial doubt about the Company's ability to continue as a going concern to exist within one year from the date of this report.”View the 10-Q filed Aug 7, 2026
Market Cap
$848,783
Shares
3.29M
Avenue Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Avenue Therapeutics, Inc. (ATXI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
No Earnings Calls Available
No earnings call events are available for this stock yet.